Yahoo Finance

Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.70, marking a -3.29% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.
IEEE

RISTRA: Recursive Image Super-Resolution Transformer With Relativistic Assessment

Abstract: Many recent image restoration methods use Transformer as the backbone network and redesign the Transformer blocks. Differently, we explore the parameter-sharing mechanism over Transformer ...
The Globe and Mail

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Yahoo Finance

Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...
IEEE

A Data-Reuse Regularized Recursive Least-Squares Adaptive Filtering Algorithm

Abstract: The recursive least-squares (RLS) algorithm is very popular for adaptive filtering applications, mainly due to its fast convergence rate. The regularized version of this algorithm owns ...